Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study

BACKGROUND: Treatment of acute myeloid leukemia (AML) in elderly patients remains a great challenge. In this prospective single arm study (ChiCTR-OPC-15006492), we evaluated the efficacy and safety of a novel consolidation therapy with low-dose decitabine (LD-DAC) priming with intermediate-dose cyta...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoyang, Dong, Yuexin, Li, Ya, Ren, Ruibao, Wu, Wen, Zhu, Hongming, Zhang, Yunxiang, Hu, Jiong, Li, Junmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701020/
https://www.ncbi.nlm.nih.gov/pubmed/31429724
http://dx.doi.org/10.1186/s12885-019-5975-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701020/
https://www.ncbi.nlm.nih.gov/pubmed/31429724
http://dx.doi.org/10.1186/s12885-019-5975-8

Ejemplares similares